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Modulation of the activity of tumor suppressor p53 is a key event in the replication of many viruses. We have
studied the function of p53 in African swine fever virus (ASFV) infection by determining the expression and
activity of this transcription factor in infected cells. p53 levels are increased at early times of infection and are
maintained throughout the infectious cycle. The protein is transcriptionally active, stabilized by phosphory-
lation, and localized in the nucleus. p53 induces the expression of p21 and Mdm2. Strikingly, these two proteins
are located at the cytoplasmic virus factories. The retention of Mdm2 at the factory may represent a viral
mechanism to prevent p53 inactivation by the protein. The expression of apoptotic proteins, such as Bax or
active caspase-3, is also increased following ASFV infection, although the increase in caspase-3 does not appear
to be, at least exclusively, p53 dependent. Bax probably plays a role in the induction of apoptosis in the infected
cells, as suggested by the release of cytochrome c from the mitochondria. The significance of p21 induction and
localization is discussed in relation to the shutoff of cellular DNA synthesis that is observed in ASFV-infected
cells.
The tumor suppressor p53 plays a pivotal role in the cellular
response to DNA damage, as it controls DNA repair, cell cycle
arrest, and apoptosis (24). A major target for p53 is the p21
gene, which encodes an inhibitor of cyclin-dependent kinases
(cdks). p21, which also binds to proliferating cell nuclear an-
tigen (PCNA), thus inhibiting PCNA-dependent DNA repli-
cation (18), plays important roles in regulating cell cycle arrest
or progression, DNA methylation, cell senescence, apoptosis,
and differentiation. After DNA damage, this p21-dependent
response allows the opportunity for DNA repair before entry
of the cell into S phase. p53 also activates apoptosis through
transcriptional control of Bax and probably other apoptotic
inducers (32).
Under normal conditions, p53 is maintained at low levels by
Mdm2 interaction and subsequent ubiquitin-dependent degra-
dation (29), but in response to stress, such as oncogenic acti-
vation, hypoxia, DNA damage, or viral infection, p53 is acti-
vated (8). Activation of p53 can be modulated at three levels:
increase of p53 expression, transformation of the protein from
a latent to an active conformation through different mecha-
nisms, and translocation of p53 to the nucleus, where it acts as
a transcriptional factor (39, 40). It is well documented that
DNA damage leads to phosphorylation on Ser/Thr-Pro motifs
and activation of p53 (8, 23). Although the mechanisms of p53
activation are still not fully understood, several kinases have
been identified that detect genotoxic stress and initiate signal-
ing pathways through p53 phosphorylation (61). p53 works
fundamentally as a transcription factor, and its nuclear import
or retention is essential for its function in induction of apo-
ptosis or growth inhibition (2).
For many viruses, replication depends on the induction of S
phase, which often leads to increased levels of p53. Since
activation of p53 can induce apoptosis, such viruses have
evolved strategies for counteracting either p53 activation or
programmed cell death. DNA tumor viruses interfere with p53
function through multiple mechanisms. The papillomavirus E6
protein interacts directly with p53, promoting its degradation
(46), and Epstein-Barr virus also regulates p53 function
through the BZLF1 early protein (28). Many members of the
herpesvirus family have also been shown to manipulate p53 for
their own purposes, using specific viral proteins: for instance,
the Kaposi’s sarcoma-associated herpesvirus open reading
frame K8 protein (37) and the cytomegalovirus IE2 protein
(21) stabilize p53, thus increasing the overall levels of p53 but
inhibiting its transactivation ability (13). A similar function has
also been described for the human adenovirus E4ORF 6 pro-
tein (13). On the other hand, the hepatitis B virus X protein
counteracts p53 by preventing its nuclear localization (51) and
DNA binding (57). Thus, the modulation of p53 seems to be an
important event for the replication of many viruses, since mul-
tiple viral strategies have been developed to regulate p53 func-
tion.
In this report, we investigate the relation between African
swine fever virus (ASFV) and p53 during the viral infection to
gain a better understanding of the interaction of the virus with
the infected cell and the mechanisms involved in apoptosis, a
process associated with both in vivo and in vitro infections (7,
34). ASFV is a complex enveloped deoxyvirus of the family
Asfarviridae that infects domestic and wild pigs, causing an
acute and frequently fatal disease (53). The analysis of the
DNA sequence of the virus has revealed the presence of sev-
eral genes able to modulate host-virus interactions (59).
Among these, A179L, which encodes a 19-kDa protein struc-
turally similar to the members of the Bcl-2/Bax family, and
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A224L, which encodes a 27-kDa protein homologous to IAP
family members, have been shown to inhibit apoptosis (1, 34,
43, 44). It has also been reported that ASFV induces apoptosis
in the cell in a postbinding step, during or after virus uncoating,
through the activation of caspases (7).
Here, we show that p53 expression is enhanced in Vero cells
from early times after ASFV infection. p53, which is stabilized
by phosphorylation and is located in the nucleus, is functionally
active during infection, inducing the expression of p21 and
Mdm2. Bax expression is also increased during infection, prob-
ably playing a role in the induction of apoptosis in the infected
cell, as suggested by the release of cytochrome c from the
mitochondria. Unexpectedly, Mdm2 and p21 are found at the
cytoplasmic virus factories, which may suggest the existence of
virus-mediated mechanisms to retain these proteins in the cy-
toplasm. The implications of this finding in relation to p53
function in the infected cell are discussed.
MATERIALS AND METHODS
Cells and virus. Vero cells were obtained from the American Type Culture
Collection and grown in Dulbecco’s modified Eagle Medium supplemented with
5% newborn calf serum (Gibco) and containing 2 mM L-glutamine, 100 U of
gentamicin per liter, and nonessential amino acids at 37°C in 7% CO2 in air
saturated with a water vapor incubator. The Vero-adapted ASFV strain BA71V
was propagated and titrated by plaque assay on Vero cells as described previ-
ously (15).
Metabolic labeling. Cultures of Vero cells were mock infected or infected with
ASFV at a multiplicity of infection of 5 PFU per cell and labeled at different
times after infection with 200 Ci of [35S]methionine-cysteine/ml (1,200 Ci/
mmol; Amersham) in cysteine-methionine-free medium for 2 h. The cells were
washed twice with cold phosphate-buffered saline (PBS), dissociated in TNT
buffer (20 mM Tris-HCl, pH 7.6, 200 mM NaCl, 1% Triton X-100) supplemented
with protease inhibitor cocktail tablets (Roche), and analyzed by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) in 7 to 20% acrylamide
gels as described previously (22). Proteins were detected by fluorography.
Cellular DNA synthesis. To study the kinetics of cellular DNA synthesis, Vero
cells were mock infected or infected with 5 PFU per cell and then pulse-labeled
for 2 h with [methyl-3H]thymidine (Amersham) at 10 Ci/ml in Dulbecco’s
modified Eagle Medium. At different times after infection, the cells were washed
and fractionated with NP-40 into nuclear and cytoplasmic fractions as previously
described (35). The acid-insoluble radioactivity in the nuclear fractions was
determined.
Western blot analysis. Mock-infected or ASFV-infected cells were washed
twice with PBS and lysed in TNT buffer supplemented with protease inhibitor
cocktail tablets. The protein concentration was determined by the bicinchoninic
acid spectrophotometric method (Pierce). Cell lysates (30 g of protein) were
fractionated by SDS–10% PAGE and electrophoretically transferred to an Im-
mobilon extra membrane (Amersham), and the separated proteins were reacted
with specific primary antibodies raised against p53 (sc-6243; Santa Cruz Biotech-
nologies), p-p53 (Ser392 and sc-7997; Santa Cruz Biotechnologies), p-p53 (Ser15
and sc-11764-R; Santa Cruz Biotechnologies), Mdm2 (sc-965; Santa Cruz Bio-
technologies), active caspase-3 (BD PharMingen), Bax (sc-493; Santa Cruz Bio-
technologies), and PCNA (BD PharMingen). The membranes were exposed to
horseradish peroxidase-conjugated secondary antibodies (Dako), followed by
chemiluminescence (ECL kit; Amersham) detection by autoradiography.
Plasmids. The p53RE-Luc reporter plasmid contains 14 tandem repeats of the
p53 consensus binding motif (Stratagene). The p21-Luc plasmid was constructed
by inserting a 2.3-kb genomic Waf 1 DNA fragment (HindIII-HindIII) from
plasmid WWP Luc (14) into the HindIII site of pGL3-Basic (Promega) and was
a generous gift from M. Serrano (Centro Nacional de Investigaciones Onlogicas,
Madrid, Spain). The Mdm2-Luc reporter plasmid contains the mouse Mdm2 P2
promoter inserted into pGL3-Basic and was a generous gift from M. Serrano.
Transfections. Vero cells were transfected with 100 ng of each specific plasmid
per 106 cells by using the Lipofectamine Plus reagent (Invitrogen) according to
the manufacturer’s instructions. Twenty-four hours after transfection, the cells
were lysed with cell culture lysis reagent (Promega) and microcentrifuged at full
speed for 5 min at 4°C, and 20 l of each supernatant was used to determine
firefly luciferase activity in a Monolight 2010 luminometer (Analytical Lumines-
cence Laboratory). The results were expressed as the number of luminescence
units after normalization of the protein concentration determined by the bicin-
choninic acid method.
Immunofluorescence and confocal microscopy. ASFV-infected cells were
grown on coverslips to 2  105/cm2 and incubated with 1 M Mitotracker Red
CM-H2Ros (Molecular Probes) to stain mitochondria. The cultures were rinsed
three times with PBS and fixed with cold 99.8% methanol (Merck) for 15 min at
20°C before they were rehydrated twice with PBS and blocked with 1% bovine
serum albumin in PBS for 10 min at room temperature. The cells were incubated
overnight with the specific antibodies, rinsed extensively with PBS, and then
incubated with the secondary antibody (Alexa; Molecular Probes) for 1 h at room
temperature in the dark. Nuclear and viral DNAs were visualized by staining the
cells with DAPI. Finally, the cells were rinsed successively with PBS, distilled
water, and ethanol and mounted with a drop of Mowiol on a microslide. Visu-
alization of the stained cultures was performed under a fluorescence Axioskop2
plus (Zeiss) microscope coupled to a color charge-coupled device camera or to
Confocal Microradiance (Bio-Rad) equipment. The images were digitized, pro-
cessed, and organized with Metamorph, Lasershap2000 version 4, Adobe Pho-
toshop version 7.0, Adobe Illustrator version 10, and Microsoft PowerPoint SP-2
software.
RESULTS
Induction of p53 and expression of p53 target genes follow-
ing ASFV infection. ASFV induces a blockage of cellular DNA
and protein synthesis in the infected cells, as demonstrated by
the data shown in Fig. 1A and B. In an attempt to investigate
the mechanism involved in the shutoff induced by the virus, we
determined whether p53 or p21 accumulate upon infection,
since p53 is a transcriptional activator that exerts part of its
cytostatic effect through the induction of p21. Extracts of
ASFV-infected or mock-infected Vero cells were prepared at
various times after infection, and 30 g from each sample was
separated by SDS-PAGE and blotted with specific antibodies
to p53 and the p53 target p21 gene. As shown in Fig. 1C, small
amounts of p53 and p21 were observed in uninfected cells but
increased after infection. While the increase in p53 could be
detected 3 h postinfection (p.i.), a delay of several hours in the
expression of p21 was observed, as would be expected for a
p53-dependent gene. The expression of the proapoptotic Bax
gene, another p53-dependent gene, was also examined in in-
fected cells. As can be seen in Fig. 1C, the kinetics of Bax
expression closely parallels that of p21, with maximal levels at
13 h p.i., a time at which activation of caspases is observed (7).
On the other hand, since PCNA is involved in DNA replica-
tion, acting as a processivity factor for DNA polymerases, we
also examined the expression of this protein in infected cells.
In contrast to p21, the levels of PCNA do not change at any
time after infection (Fig. 1C) with respect to those detected in
mock-infected cells.
To better understand the role of p53, we studied the p53
transcriptional function during ASFV infection. To achieve
this, we transfected into Vero cells a plasmid that contains the
luciferase reporter gene cloned under the control of 14 p53-
binding DNA sequences. Twelve hours after transfection, the
cells were mock infected or infected with ASFV, and at differ-
ent times postinfection, cell extracts were prepared and lucif-
erase activity was measured in a luminometer. As shown in Fig.
1D, luciferase activity increased during infection, indicating
that p53 was expressed in an active form.
As mentioned in the introduction, p53 functions primarily as
a transcription factor that triggers cell cycle arrest or apoptosis
by inducing a growing number of proteins (55), among them
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FIG. 1. ASFV inhibition of cellular DNA and protein synthesis is concomitant with the expression of cellular proteins that control the cell cycle.
(A) Cellular DNA synthesis was determined as described in Materials and Methods. The radioactivity incorporated at the indicated times of
infection into nuclear fractions from 2  106 cells (the number of cells in the culture at the time of infection) was measured. Protein synthesis was
determined by measuring the incorporation of [35S]methionine into acid-insoluble material from 2  106 cells. For both DNA and protein
synthesis, the ratio between ASFV-infected and mock-infected cultures is represented in the graph. TCA, trichloroacetic acid. (B) Cultures of Vero
cells (5  105) were mock infected (M) or infected with ASFV and labeled at different times after infection with 200 Ci of [35S]methionine-
cysteine/ml in cysteine-methionine-free medium for 2 h. The cells were resuspended in 250 l of TNT buffer, and cell extracts (10 l) were analyzed
by SDS-PAGE. Proteins were detected by fluorography. (C) Kinetics of p53, p21, Bax, and PCNA expression analyzed by Western blotting in
mock-infected (M) or ASFV-infected Vero cells. Times after infection are indicated above the lanes. (D) The p53 transcriptional activity was
analyzed in mock-infected or ASFV-infected Vero cells by transient transfection of specific plasmids containing the luciferase gene under the
control of p53-binding motif or of p21 or Mdm2 promoters, as indicated in Materials and Methods. The transfected cells were incubated overnight
and then infected with BA71V at a multiplicity of infection of 5 PFU/cell. At the indicated times after infection, cell extracts were prepared, and
the luciferase activity was measured in a luminometer. RLU, relative light units.
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p21 and Mdm2 (40). To examine whether Mdm2 and p21 gene
promoters are activated during ASFV infection, we used Vero
cells transiently transfected with plasmids containing the lucif-
erase reporter gene cloned under the control of the p21 or
Mdm2 gene promoter. Twelve hours after transfection, the
cells were mock infected or infected with ASFV, and at differ-
ent times postinfection, cell extracts were prepared and ana-
lyzed for luciferase activity. As shown in Fig. 1D, the activities
of Mdm2 and p21 gene promoters increased from 13 h p.i.,
consistent with the increased activity of p53.
Phosphorylation of p53 and localization at the nucleus.
Since the nuclear localization of p53 is related to its activation
(25), we next examined the subcellular localization and the
phosphorylation state of p53 upon ASFV infection. The p53
protein is known to be phosphorylated at multiple sites located
in both the N- and C-terminal regions. The amino terminus of
p53, which contains the transcriptional regulatory domain, has
eight phosphorylation sites (4). The carboxyl terminus contains
the nuclear import and export signals, the tetramerization do-
main, and four phosphorylation sites (serines 315, 376, 378,
and 392). Although it is not clear whether this elevated p53
phosphorylation is directly involved in the p53 nucleocytoplas-
mic translocation, it has been speculated that phosphorylation
may affect p53 localization and activation. Thus, phosphoryla-
tion of p53 appears to enhance p53 transcriptional activity and
to render it more resistant to inhibition by Mdm2 (48).
To investigate the localization of p53 following ASFV infec-
tion, we incubated mock-infected or ASFV-infected Vero cells
with the specific anti-p53 antibody. Using confocal microscopy,
we could demonstrate that p53 shows a nuclear localization
from 4 h p.i. (Fig. 2A); the nuclear signal is enhanced at later
times of infection.
To determine whether the nuclear p53 is phosphorylated,
nuclear and cytosolic fractions were obtained from ASFV-
infected cells, at different times after infection. The fractions
were standardized for protein concentration (30 g) and ana-
lyzed by Western blotting using the specific anti-p53 antibody.
As shown in Fig. 2B, two closely migrating bands were recog-
nized by the anti-p53 antibody in the nuclear fraction; the
upper band probably represented the phosphorylated form of
p53. The intensity of the upper band could also be observed to
increase at late times after infection. To confirm that this band
corresponded to a phosphorylated form of p53, we incubated
the nuclear fractions with a specific antibody against p-p53,
Ser392, which recognizes the specific site 392 when phosphor-
ylated. As shown, a band with a molecular weight similar to
that of the upper band previously detected with the anti-p53
serum was observed when the anti-p-p53 antibody was used.
From this result, we conclude that this band corresponds to
phosphorylated p53, which appears in the nuclear fraction
from the infected cells and not in mock-infected cells or in
cytoplasmic fractions from ASFV-infected cells (not shown). It
should be noted that phosphorylation of p53 at Ser392 is an
early response to a wide range of stress-inducing conditions (3,
9). Phosphorylation at Ser15 is also a response to DNA dam-
age and viral infections and has been shown to alleviate inhi-
bition of p53 by Mdm2 (48, 52). In the case of ASFV, as shown
in Fig. 2B, it seems that phosphorylation at this residue does
not increase after ASFV infection, suggesting that this mech-
anism is not used by the virus to inhibit p53-Mdm2 interaction.
Localization of p21, Mdm2, and PCNA. We have demon-
strated above that p21, which inhibits cell cycle progression by
binding to G1 cyclin-cdk and PCNA (14, 19), is accumulated
after ASFV infection. This raises the possibility that the shutoff
FIG. 2. Subcellular localization and phosphorylation of p53 during ASFV infection. (A) Mock-infected or ASFV-infected Vero cells were
labeled with Mitotracker (red) and anti-p53 antibody (green) and then examined by confocal microscopy. Shown are images corresponding to one
of three independent experiments performed. (B) Nuclear extracts (30 g) from mock-infected or ASFV-infected Vero cells were subjected to
Western blot analysis using an anti-p53 (p53) antibody (left) or anti-p-p53 antibodies that recognize phosphorylated p53 in Ser392 (center) or
in Ser15 (right).
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of cellular DNA synthesis, which occurs in the infected cells by
an unknown mechanism, could be due to the increased levels
of p21. Since the cell cycle-inhibitory activity of p21 is inti-
mately correlated with its nuclear localization (5), we investi-
gated the subcellular localization of p21 after ASFV infection
by confocal microscopy of mock-infected or ASFV-infected
Vero cells, using a specific anti-p21 antibody. Surprisingly, the
protein does not localize in the nucleus but accumulates in the
cytoplasm of infected cells after 13 h p.i. (Fig. 3A), mainly
associated with discrete structures that correspond to the virus
factories, as indicated by staining of the viral DNA with DAPI
(Fig. 3B). In relation to this finding, it should be mentioned
that a short form of p21 is present in the cytoplasm of UV-
treated cells (38) and that phosphorylation of p21 by Akt also
leads to its cytoplasmic localization (62). However, when the
phosphorylation state of p21 was examined by Western blot-
ting using an antibody specific for phosphorylated Ser146, we
could not detect an increase in the phosphorylated form of p21
after infection (data not shown).
It is known that in normal, nonstressed cells, p53 has a very
short half-life due to a feedback mechanism in which the
Mdm2 protein plays a key role. Wild-type p53 acts as a tran-
scriptional activator of the Mdm2 gene; in turn, Mdm2 has the
ability to interact with p53 and to function as a ubiquitin E3
ligase that promotes the conjugation of p53 to polyubiquitin
and its posterior degradation by the proteasome (49). It has
also been established that the nuclear localization of Mdm2 is
required to inhibit the transcriptional function of p53 (33).
Therefore, we investigated the localization of Mdm2 during
the viral cycle. For this, we analyzed Vero cells at different
times after ASFV infection by confocal microscopy using a
specific anti-Mdm2 antibody. Representative fields are shown
in Fig. 3A. As can be seen, in mock-infected cells and at early
times after infection (4 h p.i.), the localization of Mdm2 is
mainly nuclear. However, as the infection progresses, Mdm2
accumulates in the cytoplasm, focalized in areas corresponding
to virus factories. As in the case of p21, the colocalization of
Mdm2 with these virus structures was confirmed by DAPI
staining (Fig. 3B) and supported by the fact that the label
corresponding to p21 or Mdm2 in cells infected at 13 and 22 h
p.i. appeared to be surrounded by mitochondria (Fig. 3A), as
expected for ASFV factories (45).
In contrast with the cytoplasmic localization of p21, PCNA,
a protein whose expression does not change at any time after
infection, was localized in the nucleus in both mock-infected
and ASFV-infected cells (Fig. 3A), a distribution consistent
with the function of the protein in DNA replication.
These results might suggest that Mdm2 and p21 are seques-
tered in the cytoplasm by an unknown viral mechanism. This
would impair p53-Mdm2 interaction, allowing the stabilization
of p53 and its function as a transcriptional factor. On the other
hand, the cytoplasmic localization of p21 indicates that the
function of the protein, if any, during ASFV infection would
not be mediated through its interaction with PCNA.
Role of p53 in the induction of apoptosis during ASFV
infection. ASFV induction of apoptosis in an early step of
infection has been described (7). ASFV-infected Vero cells
showed several apoptotic signs after 13 h p.i., including the
release of cytochrome c from the mitochondria to the cytosolic
fraction as detected by immunoblot analysis. We have now
examined this release of cytochrome c by confocal microscopy
using specific anti-cytochrome c antibody. Figure 4A shows
that in mock-infected cells, cytochrome c colocalizes with the
mitochondria. The release of cytochrome c from the organelle
starts 4 h after infection, and from 13 to 22 h p.i., most of the
protein is localized throughout the cytoplasm, including the
virus factory. This free cytochrome induces the activation of
effector caspases and therefore the accumulation of the cata-
lytic fragment of caspase-3, which is observed in the infected
cells (7, 34).
To study the involvement of p53 in the induction of apopto-
sis and the activation of caspase-3, Vero cells, previously incu-
bated or not with 10 g of cycloheximide (CHX)/ml, were
infected with 5 PFU of BA71V/cell, and at 18 h p.i., cell
extracts were prepared and examined by Western blotting us-
ing specific antibodies against p53 and the active fragment of
caspase-3. Figure 4B shows that p53 is not present in ASFV-
infected cells in the presence of CHX; however, the active
fragment (17 kDa) of caspase-3 is detected under these con-
ditions, indicating that protein synthesis is not required for the
activation of caspase-3, and more relevant, that the activation
of caspase-3 is, at least in part, a p53-independent event.
In order to determine the roles of viral proteins in the
induction of both p53 expression and caspase-3 activity, we
treated the cells with cytosine arabinoside (CAR), which in-
hibits virus DNA replication and late protein synthesis but
allows the synthesis of early proteins. In the presence of CAR
(40 g/ml), two bands, corresponding to nonphosphorylated
(lower) and phosphorylated (upper) p53, could be detected in
mock-infected cells (Fig. 4B). Upon infection with ASFV, only
the phosphorylated form was observed. These results demon-
strate that the synthesis of ASFV late proteins is not required
for the induction of the phosphorylated form of p53. The
17-kDa band corresponding to active caspase-3 is also detected
under these experimental conditions. On the other hand, and
as also shown in Fig. 4B, no p53 is detected when the cells are
infected with UV-irradiated virus, suggesting that early viral-
gene expression is needed for p53 induction. In order to see
whether the p53 expressed in the presence of CAR was tran-
scriptionally active, we transiently transfected Vero cells with a
plasmid containing the reporter luciferase gene under the con-
trol of specific DNA-binding sequences for p53. After 12 h, the
cells were mock infected or infected under the different con-
ditions described in the legend to Fig. 4B. The results pre-
sented in Fig. 4C show that the activity of p53 induced in cells
infected in the presence of CAR was similar to that found in
the absence of the inhibitor. No significant p53 activity was
detected in cells infected with UV-irradiated virus or in the
presence of CHX.
DISCUSSION
The present study provides a number of novel observations
pertaining to the regulation and functional role of p53 during
ASFV infection. It has been shown that ASFV induces apo-
ptosis after 13 h in the cell, a time at which viral morphogenesis
is well under way (7). It was also shown that several ASFV
genes are involved in the inhibition of apoptosis using different
mechanisms (34, 43, 44), thus demonstrating that programmed
cell death during ASFV infection is a tightly regulated process
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in which the action of inducers is balanced by the expression of
antiapoptotic genes. However, less information is available on
the process of ASFV-induced apoptosis in terms of the cellular
pathways and specific proteins involved. In a recent report (7),
it was shown that the apoptotic signal in ASFV-infected Vero
cells is activated in the absence of virus replication and before
early ASFV protein synthesis by an intracellular pathway prob-
ably triggered during the process of virus uncoating.
FIG. 3. Subcellular localization of p21, Mdm2, and PCNA. (A) Mock-infected or ASFV-infected Vero cells were labeled with Mitotracker (red)
and anti-p21, anti-Mdm2, or anti-PCNA antibodies (green) and then examined by confocal microscopy. Shown are images corresponding to one
of three independent experiments performed. (B) ASFV-infected Vero cells were stained at 13 h p.i. with DAPI (blue) and anti-p21 or anti-Mdm2
antibodies (green) and examined by fluorescence microscopy. The arrows point to virus factories identified by DAPI staining.
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Here, we report the expression and the transcriptional ac-
tivity of p53 observed in ASFV-infected Vero cells from 4 h
p.i., with a maximum between 18 and 24 h p.i. Using confocal
microscopy, we detected p53 in the nuclei of the cells at the
same times after infection. Studies of the phosphorylation state
of p53 in cytoplasmic and nuclear extracts from ASFV-infected
cells demonstrated that phosphorylated p53 accumulates in the
nucleus during ASFV infection, thus confirming the rapid im-
port and retention in the nucleus of p53 detected by confocal
fluorescence. This supports a role for phosphorylation in p53
nucleocytoplasmic translocation, as has been previously sug-
gested (25). Working principally as a transcriptional factor, p53
nuclear import or retention is essential for its normal function
in cell cycle inhibition or apoptosis induction.
FIG. 4. ASFV-induced cytochrome c release and expression of p53 and caspase-3 activation under different infection conditions. (A) Mock-
infected or ASFV-infected Vero cells were labeled with Mitotracker (red) and anti-cytochrome c (Cit-C) antibody (green) and then examined
by confocal microscopy. Colocalization of mitochondria and cytochrome c yields a yellow signal. Shown are images corresponding to one of two
independent experiments performed. (B) Extracts from mock-infected cells (M), ASFV-infected cells (V), cells incubated with UV-inactivated
virus (UVV), cells mock infected (CHX/M) or infected (CHX/V) in the presence of CHX (10 g/ml), and cells mock infected (CAR/M) or infected
(CAR/V) in the presence of CAR (40 g/ml) were analyzed by Western blotting using specific antibodies against p53 ( p53) or caspase-3 (
casp.3). A representative experiment is shown. (C) Luciferase activity in Vero cells transfected with the p53RE-Luc reporter plasmid. Twelve hours
after transfection, the cells were mock infected or infected under the conditions described for panel B, and cell extracts were prepared and analyzed
for p53 transcriptional activity. The results of a representative experiment are shown. a.u., arbitrary units.
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Interestingly, Mdm2, an inhibitor of p53 activity, is found in
the cytoplasm of ASFV-infected cells, localized within cellular
structures corresponding to virus factories. This finding raises
the possibility that Mdm2 could be retained in the cytoplasm
by a specific virus-mediated mechanism, thus hindering the
entry of Mdm2 into the nucleus and its interaction with p53.
This would imply that the virus needs to maintain active p53
for its replication. Further studies are required to confirm this
attractive hypothesis.
The elucidation of the mechanisms by which p53 is activated
when cells are subjected to stress has been an area of intense
research (2). It has been well documented that several types of
DNA damage, including double-strand breaks in DNA and the
presence of DNA repair intermediates (11, 24, 26, 39), induce
a rapid increase in the level of p53 and its activation as a
transcription factor, which are proportional to the extent of
DNA damage. In relation to this, it is interesting that most
viruses that induce p53, such as simian virus 40 (16, 30), poly-
omavirus (12), papillomavirus (36, 46), adenovirus (27, 41),
and herpesvirus (37), replicate in the nucleus of the infected
cell. ASFV also has an early nuclear stage of replication (17).
It is possible that repair events that could play a role in trig-
gering the activation of p53 might occur during this nuclear
phase.
It is also possible that p53 activation might be related to the
induction of free radicals, probably released from the mito-
chondria during ASFV infection. Reactive oxygen species-me-
diated mitochondrion-dependent pathways are suggested as
major pathomechanisms contributing to nuclear DNA dam-
age, which eventually may result in increased levels of p53 (56).
In this connection, previous data from our laboratory showed
the presence of large clusters of mitochondria located in prox-
imity to the virus factories (45). Interestingly, ASFV infection
also promotes the induction of the mitochondrial stress-re-
sponsive proteins p74 and cpn 60 concomitant with a change in
the organelle toward the morphology characteristic of actively
respiring mitochondria (45). These activated mitochondria
might release reactive oxygen species that could account for
the high p53 levels that are maintained at late times postinfec-
tion.
On the other hand, p53 can be activated in the absence of
DNA damage. For instance, it has been proposed that certain
viral oncoproteins can also increase the level of p53 (10). This
activation, at least in some situations, is mediated by an in-
crease in the levels of expression of ARF (58), an antagonist of
Mdm2 function that forms complexes with p53 and Mdm2 and
both stabilizes p53 and enhances its transactivation activity
(47). However, this is not the more plausible explanation for
the induction of p53 during ASFV infection, because we did
not detect ARF expression in ASFV-infected cells by Western
blotting (data not shown).
On the other hand, it is worthy of note that some ASFV
proteins have been reported to interact with NFB (42) and
NFAT (31) signaling pathways. In relation to this, it has been
established (60) that sanglifehrin A, a member of the immu-
nophilin-binding ligands, activates p53 transcription primarily
through the activation of NFB by activating IB kinase. Our
previous finding that A224L, an ASFV protein homologous to
the members of the IAP family, induces the activation of NFB
(44) provides still another possible explanation for p53 induc-
tion in ASFV-infected cells.
Several lines of evidence support the hypothesis that activa-
tion of p53 induces either cell cycle arrest or apoptotic cell
death under different stress conditions (50, 55). The cytostatic
effect of p53 is mediated by transcriptional activation of p21,
which inhibits the cdks (19) and binds to PCNA, thus inhibiting
PCNA-dependent DNA replication (18). During ASFV infec-
tion, we detected both p21 expression and activation of the p21
gene promoter, although the significance of these events in
relation to the shutoff of cellular DNA synthesis is not clear at
present. Since we have not been able to demonstrate an inter-
action between p21 and PCNA, in accordance with the finding
that the two proteins are localized in different compartments of
the infected cells, a possible effect of p21 on the observed cell
cycle arrest cannot be mediated by this mechanism. An alter-
native possibility would be that p21 could bind and retain in the
cytoplasm certain cdk-cyclin complexes that may be involved in
the initiation of DNA replication (20). Work is now in progress
to explore this possibility.
The mechanisms by which p53 induces apoptosis in cells are
still unresolved (54). The apoptotic effect of p53 is mediated by
transcriptional activation of the Bax gene and other BH-3
domain-containing genes, which encode downstream activators
of apoptosis (6). Regarding the role of p53 in the induction of
the apoptosis observed during ASFV infection, the increase
detected in the expression of Bax is noteworthy. Furthermore,
using confocal microscopy, we could also detect the release of
cytochrome c from the mitochondria from 13 h p.i., an event
directly related to the overexpression of Bax. The released
cytochrome c is mainly found in the virus factory, which may be
simply a consequence of the accumulation of the mitochondria
around this area at these times postinfection. However, a
weaker but significant signal is also detected in the cytoplasm
outside the assembly sites. This cytosolic cytochrome c could
be responsible for the caspase activation that is observed in
infected cells at these times postinfection (34). These findings
support the existence of a p53-initiated apoptotic pathway in
ASFV-infected cells, although other apoptotic mechanisms
may operate as well. This is suggested by the finding that, when
the cells are infected in the presence of CHX, caspase-3 acti-
vation is observed, but no p53 expression is detected. This
could indicate that the apoptosis induced by ASFV is, at least
in part, a p53-independent process. Similar results in terms of
activation of caspase-3 were obtained during ASFV infection
in the presence of CAR, although p53 was active under these
conditions. These results, together with the observation that
p53 is not detected when the cells are infected with UV-irra-
diated virus, suggest that p53 induction is probably related to
the expression of early proteins of ASFV and that, as with
many other viruses, ASFV can also kill cells through the acti-
vation of p53-independent mechanisms.
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